Bolt Biotherapeutics logo

BOLT

NASDAQ

Bolt Biotherapeutics

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$8.24M
P/E RatioN/A
Div. Yield
EPS (TTM)-$17.85
52W High$9.25
52W Low$3.91
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees23
Price Performance
1 Week-2.05%
3 Month-24.20%
1 Year-45.75%
FinancialsAnnual · QuiverQuant
Revenue$7.88M
Assets$159.78M
Liabilities$47.04M
Net Income$69.20M loss

About

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze BOLT with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.